Showing results (1811-1820 of 2,072) with videos related to
Sort By:
Pageof 208
IJID Regions|July 1, 2026
Forensic postmortem examination as sentinel evidence of rifampicin-resistant tuberculosis outside routine clinical reportingNathan M Kayonde, Bwalya Mulenga, Cordilia M Himwaze, et al.American Journal of Hematology|August 31, 2021
Cytogenetic and molecular abnormalities in Waldenström's macroglobulinemia patients: Correlations and prognostic impactDaphné Krzisch, Nayara Guedes, Clémentine Boccon-Gibod, et al.Diagnostics (Basel, Switzerland)|September 14, 2024
Comparative Performance of <sup>68</sup>Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical ProstatectomyGuido Rovera, Serena Grimaldi, Marco Oderda, et al.Scientific Reports|August 12, 2017
Wet tropical climate in SE Tibet during the Late EocenePhilippe Sorrel, Ines Eymard, Philippe-Herve Leloup, et al.MMWR. Morbidity and Mortality Weekly Report|May 5, 2017
Progress Toward Measles Elimination - African Region, 2013-2016Balcha G Masresha, Meredith G Dixon, Jennifer L Kriss, et al.The Journal of Biological Chemistry|September 25, 2009
Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspectiveEric M Jacobson, Heyi Yang, Francesca Menconi, et al.Stem Cells Translational Medicine|April 17, 2014
Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrityClara Steichen, Eléanor Luce, Jérôme Maluenda, et al.The Journal of Pain|December 3, 2014
Persistent arm pain is distinct from persistent breast pain following breast cancer surgeryDale J Langford, Steven M Paul, Claudia West, et al.The Journal of Infectious Diseases|May 21, 2020
Chronic and Early Antiretroviral Therapy Impact Human Immunodeficiency Virus (HIV) Serological Assay Sensitivity, Leading to More False-Negative Test Results in HIV DiagnosisKarolien Stoffels, Fien Vanroye, Virginie Mortier, et al.BMC Cancer|July 10, 2015
Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial--the PRODIGE 22--ECKINOXE trialMehdi Karoui, Anne Rullier, Alain Luciani, et al.Pageof 208